Jianwen Guo and colleagues’ trial1 on using FYTF-919 for acute intracerebral haemorrhage has sparked considerable discussion across China's medical community and social media. Although many commend ...

For more than 80 years, the US Government has invested in biomedical, clinical, and public health research, making it a world ...

In May, 2025, the World Health Assembly (WHA) will vote on re-establishing a mandate for WHO to address the health ...

New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...

Estimated energy requirements (EERs) are used every day for diverse purposes. In clinical care they provide the basis to plan ...

Colombia's progressive drug policy reforms include the prioritisation of harm reduction, but campaigners fear advances are at risk. Jacqui Thornton reports.

Treatment-resistant schizophrenia is a disabling illness, affecting approximately 8 million people worldwide with profound ...

Many African countries have long relied on overseas development aid to implement health programmes. Unfortunately, this aid ...

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with atherosclerotic cardiovascular ...

The prevalence of SVAC is extremely high for both females and males across the globe. Given data sparsity and ongoing ...

We evaluated the effects of digital health technologies (DHTs) on women's health, empowerment, and gender equality, using the ...

Mexico's type 2 diabetes crisis, with a prevalence of 16·9%, has made the country a focal point for fiscal policies targeting ...